Vasotec and Multihance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vasotec (enalapril maleate) and Multihance (gadobenate dimeglumine). Common drug interactions include nephrogenic systemic fibrosis among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Vasotec and Multihance. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Vasotec?

Vasotec has active ingredients of enalapril maleate. It is often used in high blood pressure. eHealthMe is studying from 14,646 Vasotec users. Check the latest studies of Vasotec.

What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,786 Multihance users. Check the latest studies of Multihance.

On Jul, 14, 2026

28 people who take Vasotec and Multihance together, and have interactions are studied.

Vasotec and Multihance drug interactions.

What are the common drug interactions of Vasotec and Multihance, by gender? *:

female:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Skin tightness
Skin induration (an abnormally hard spot or area on the skin)
Pain in extremity
Erythema (redness of the skin)
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Oedema peripheral (superficial swelling)

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Injury
Neuropathy peripheral (surface nerve damage)
Sensory loss (senses loss)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Skin induration (an abnormally hard spot or area on the skin)
Arthralgia (joint pain)
Bone pain
Deformity (disfigurement)

What are the common drug interactions of Vasotec and Multihance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Mobility decreased (ability to move is reduced)
Muscle tightness
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Pruritus generalised (generalized itching)
Rash erythematous (redness of the skin)
Scar
Skin discolouration (change of skin colour)
Skin hypertrophy (skin cells enlarges)

30-39:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Skin induration (an abnormally hard spot or area on the skin)
Axonal neuropathy (dysfunction of axon nerves)
Deformity (disfigurement)
Erythema (redness of the skin)
Muscle spasms (muscle contraction)
Myositis (inflammation of the muscles)
Rash
Rash papular (redness with papule)

40-49:

Anaphylactic reaction (serious allergic reaction)

50-59:

Injury
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Anxiety
Emotional distress
Mobility decreased (ability to move is reduced)
Skin tightness
Oedema peripheral (superficial swelling)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
General physical health deterioration (weak health status)

60+:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Erythema (redness of the skin)
Arthralgia (joint pain)
Bone pain
Deformity (disfigurement)
Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
Eye disorder
General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)

What are the existing conditions these people have? *

Diabetes: 5 people, 17.86%
Computerised Tomogram Abdomen: 5 people, 17.86%
Anaemia (lack of blood): 3 people, 10.71%
Nuclear Magnetic Resonance Imaging Brain: 2 people, 7.14%
Cardiac Failure Chronic: 2 people, 7.14%
Blood Pressure Abnormal: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Vasotec and Multihance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously